XGene’s Non-Opioid Pain Contender Shows Pre-/Post-Op Promise

Potential Competitor For Vertex?

 
• By Xu Hu
  
Pain relief
XGene Pharmaceutical's non-opioid, dual-targeting analgesic XG005 showed positive topline Phase IIb/III results in acute pain. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from Therapy Areas